These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8117986)

  • 1. [Rubomycin-induced cardiomyopathy in rats and the potential for therapy with a peptide preparation from the heart].
    Andreeva LI; Khavinson VKh
    Biull Eksp Biol Med; 1993 Sep; 116(9):233-5. PubMed ID: 8117986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphological manifestations of anthracycline cardiomyopathy in the ventricular myocardium of the rat].
    Semenov DE; Nepomniashchikh LM; Semenova LA
    Biull Eksp Biol Med; 1987 Jul; 104(7):113-6. PubMed ID: 3620638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative analysis of the changes in myocardial electrical and contractile activity in rats exposed to rubomycin and its nitroxyl derivative].
    Vasilets LA; Guseva TI; Mokh VP
    Farmakol Toksikol; 1985; 48(6):33-7. PubMed ID: 4085626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Free-radical lipid oxidation and DNA synthesis in the heart in adriablastin-induced cardiomyopathy and the action of the antioxidant ionol].
    Meerson FZ; Nurmukhambetov AN; Dzhanbaeva GE; Gutkin DV
    Patol Fiziol Eksp Ter; 1987; (4):66-8. PubMed ID: 3684341
    [No Abstract]   [Full Text] [Related]  

  • 5. [The current possibilities for the pharmacological regulation of myocardial metabolism in experimental catecholamine-induced necroses].
    Sysoliatina NA; Artamonova VV
    Eksp Klin Farmakol; 1998; 61(1):70-3. PubMed ID: 9575418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterative and plastic insufficiency of cardiomyocytes: isoproterenol-induced damage to myocardium during anthracycline cardiomyopathy.
    Lushnikova EL; Nepomnyashchikh LM; Semenov DE
    Bull Exp Biol Med; 2001 Jun; 131(6):589-94. PubMed ID: 11586415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The phenomenon of cardiomyocyte disappearance in plastic insufficiency of the myocardium].
    Semenov DE; Semenova LA; Nepomniashchikh LM; Tsellarius IuG
    Biull Eksp Biol Med; 1984 May; 97(5):629-33. PubMed ID: 6722348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac troponin T as an indicator of reduced left ventricular contractility in experimental anthracycline-induced cardiomyopathy.
    Simůnek T; Klimtová I; Adamcová M; Gersl V; Hrdina R; Sterba M; Kaplanová J; Mazurová Y
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):431-4. PubMed ID: 14618274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The interrelationship of doses and the pharmacological effects of cardiac peptides].
    Pavlenko VS; Andreeva LI; Ershov VI; Khavinson VKh; Khlystov VV
    Biull Eksp Biol Med; 1992 Jul; 114(8):171-3. PubMed ID: 1467483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats.
    Saad SY; Najjar TA; Arafah MM
    Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):412-7. PubMed ID: 17169121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative pathomorphological study of the experimental action of carminomycin and rubomycin on the heart].
    Vinogorova GF; Khokhlova MP; Khanykova OK
    Antibiotiki; 1978 Oct; 23(10):931-4. PubMed ID: 708004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enzymatic variations and myocardial lesions in the rabbit after an administration of rubidomycin].
    Aubert C; Blache R; Begon F
    Rev Fr Etud Clin Biol; 1969 Jan; 14(1):84-7. PubMed ID: 5305804
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the toxicity and antitumor activity of a DNA-rubomycin complex and free rubomycin].
    Kim VKh; Smoryzanova OA; Riabchenko NI; Dedenkov AN
    Antibiotiki; 1981 May; 26(5):361-5. PubMed ID: 7259142
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
    Tesoriere L; Ciaccio M; Valenza M; Bongiorno A; Maresi E; Albiero R; Livrea MA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):430-6. PubMed ID: 8169849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes.
    Norby FL; Wold LE; Duan J; Hintz KK; Ren J
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E658-66. PubMed ID: 12217882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The cardioprotective action of 18-dehydroglycyrrhetic acid in experimental myocardial damage].
    Zakirov NU; Aĭzimov MI; Kurmukov AG
    Eksp Klin Farmakol; 1999; 62(2):19-21. PubMed ID: 10340122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The antioxidant hydroxypyridine-6 as an agent to prevent postresuscitation heart damage].
    Dolgikh VT
    Patol Fiziol Eksp Ter; 1991; (4):31-3. PubMed ID: 1798649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy].
    Kashuro VA; Glushkov SI; Novikova TM; Aksenov VV
    Eksp Klin Farmakol; 2010 Mar; 73(3):15-7. PubMed ID: 20408423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stereological analysis of myocardial structures in plastic heart insufficiency].
    Nepomniashchikh LM; Semenov DE; Tumanov VP; Tsellarius IuG
    Biull Eksp Biol Med; 1983 Sep; 96(9):25-9. PubMed ID: 6616047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac and peripheral actions of growth hormone and its releasing peptides: relevance for the treatment of cardiomyopathies.
    Marleau S; Mulumba M; Lamontagne D; Ong H
    Cardiovasc Res; 2006 Jan; 69(1):26-35. PubMed ID: 16219302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.